CN103705837A - Traditional Chinese medicament for treating gastric ulcer - Google Patents

Traditional Chinese medicament for treating gastric ulcer Download PDF

Info

Publication number
CN103705837A
CN103705837A CN201310746748.1A CN201310746748A CN103705837A CN 103705837 A CN103705837 A CN 103705837A CN 201310746748 A CN201310746748 A CN 201310746748A CN 103705837 A CN103705837 A CN 103705837A
Authority
CN
China
Prior art keywords
rhizoma
gastric ulcer
chinese medicament
traditional chinese
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310746748.1A
Other languages
Chinese (zh)
Inventor
蔡卓慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310746748.1A priority Critical patent/CN103705837A/en
Publication of CN103705837A publication Critical patent/CN103705837A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicament for treating gastric ulcer. The traditional Chinese medicament is prepared from the following raw materials in percentage by weight: 10-20% of cortex magnoliae officinalis, 15-25% of fried rhizoma cyperi, 7-14% of herba dendrobii, 6-12% of rhizoma atractylodis alba, 6-12% of endothelium corneum gigeriae galli, 6-10% of coptis root, 12-18% of yam, 5-10% of cardamom, 20-30% of cuttlebone, 12-20% of bletilla striata, 10-20% of nard, 10-20% of rhizoma corydalis and 3-7% of licorice. The traditional Chinese medicament for treating gastric ulcer takes the cuttlebone as a main drug matched with the other adjuvants, and the main drug and the adjuvants influence each other to achieve a synergistic effect, so that the Chinese medicament achieves very good effects of strengthening the spleen, replenishing qi, promoting blood circulation to arrest pain and relieving hyperacidity to stop bleeding, and has a very good treatment effect on gastric ulcer patients; moreover, the traditional Chinese medicament is safe, does not have toxic and side effects, and is simple in preparation method and convenient to take.

Description

A kind of Chinese medicine for the treatment of gastric ulcer
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of gastric ulcer.
Background technology
Peptic Ulcers or peptic ulcer are a kind of common digestive tract disease, can betide esophagus, stomach or duodenum, because gastric ulcer and duodenal ulcer are the most common, therefore general so-called peptic ulcer refers to gastric ulcer and duodenal ulcer.Why it is referred to as peptic ulcer, be because previously think gastric ulcer and duodenal ulcer be due to gastric acid and pepsin formed to mucosa autodigestion, in fact gastric acid and pepsin are the one of the main reasons of ulcer, also have other reasons can form peptic ulcer.The medicine for the treatment of gastric ulcer is a lot of at present, for example publication number is: CN103316221A, name is called the Chinese invention patent application of the Chinese medicine composition > > of < < treatment gastric ulcer, a kind of Chinese medicine composition for the treatment of gastric ulcer is disclosed, by following raw material by weight ratio, formed: Rhizoma Corydalis 10-15 part, Olibanum 8-12 part, Endothelium Corneum Gigeriae Galli 5-8 part, Semen Raphani 6-9 part, Radix Cynanchi Paniculati 8-12 part, Fructus Foeniculi 6-8 part, Pericarpium citri sinensis 9-12 part, Radix Et Rhizoma Nardostachyos 5-9 part, Herba Dendrobii 3-8 part, Concha Arcae 6-8 part, Pheretima 3-8 part, Fructus Litseae 6-8 part, Lignum Santali Albi 5-8 part, venushair fern 3-7 part, Herb Polygoni Chinensis 4-9 part, Fructus Dracontomeli Duperreani 5-8 part, Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 3-9 part, Fructus psidii guajavae immaturus 4-8 part.The present invention treats the Chinese medicine composition of gastric ulcer, material combination science, and each composition influences each other, brings out the best in each other, and can play the effect of invigorating the spleen and regulating the stomach, circulation of qi promoting dissipating blood stasis, pain relieving, determined curative effect, remarkable, instant effect, has no side effect.But the compatibility more complicated of this medicine.
Summary of the invention
The technical problem to be solved in the present invention is to provide the Chinese medicine of the treatment gastric ulcer that a kind of compatibility is comparatively simple, safe and reliable, therapeutic effect is good.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats the Chinese medicine of gastric ulcer, is to be made by the raw material of following weight proportioning:
Cortex Magnoliae Officinalis 10~20, stir-fry Rhizoma Cyperi 15~25, Herba Dendrobii 7~14, the Rhizoma Atractylodis Macrocephalae 6~12, Endothelium Corneum Gigeriae Galli 6~12, Rhizoma Coptidis 6~10, Rhizoma Dioscoreae 12~18, Fructus Amomi Rotundus 5~10, Endoconcha Sepiae 20~30, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12~20, Radix Et Rhizoma Nardostachyos 10~20, Rhizoma Corydalis 10~20, Radix Glycyrrhizae 3~7.
The preferred weight proportioning of each raw material is:
Cortex Magnoliae Officinalis 12~18, stir-fry Rhizoma Cyperi 18~22, Herba Dendrobii 9~12, the Rhizoma Atractylodis Macrocephalae 7~10, Endothelium Corneum Gigeriae Galli 7~10, Rhizoma Coptidis 7~9, Rhizoma Dioscoreae 14~16, Fructus Amomi Rotundus 6~9, Endoconcha Sepiae 22~28, the Pseudobulbus Bletillae (Rhizoma Bletillae) 14~18, Radix Et Rhizoma Nardostachyos 12~18, Rhizoma Corydalis 12~18, Radix Glycyrrhizae 4~6.
The optimum weight proportioning of each raw material is:
Cortex Magnoliae Officinalis 15, stir-fry Rhizoma Cyperi 20, Herba Dendrobii 11, the Rhizoma Atractylodis Macrocephalae 9, Endothelium Corneum Gigeriae Galli 9, Rhizoma Coptidis 8, Rhizoma Dioscoreae 15, Fructus Amomi Rotundus 7, Endoconcha Sepiae 25, the Pseudobulbus Bletillae (Rhizoma Bletillae) 16, Radix Et Rhizoma Nardostachyos 16, Rhizoma Corydalis 16, Radix Glycyrrhizae 5.
The preparation method that the present invention treats the Chinese medicine of gastric ulcer is: take by weight ratio raw material Cortex Magnoliae Officinalis, fry Rhizoma Cyperi, Herba Dendrobii, the Rhizoma Atractylodis Macrocephalae, Endothelium Corneum Gigeriae Galli, Rhizoma Coptidis, Rhizoma Dioscoreae, Fructus Amomi Rotundus, Endoconcha Sepiae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Nardostachyos, Rhizoma Corydalis, Radix Glycyrrhizae, add the decocting of 8~12 times of raw material weights to boil, after water boils, slow fire boils 50~80 minutes, leach medicinal liquid, obtain.
The instructions of taking that the present invention treats the Chinese medicine of gastric ulcer is: oral, every day 2 times, each serving 200~300 grams.
The Chinese medicine that the present invention treats gastric ulcer be take Endoconcha Sepiae as principal agent, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good invigorating the spleen and benefiting QI, promoting blood circulation and stopping pain, antacid hemostasia effect, patients w ith peptic ulcer disease is had to good therapeutic effect, and it has no side effect safely, preparation method is simple, and it is also convenient to take.
The specific embodiment
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
10 parts of Cortex Magnoliae Officinalis, 15 parts of Rhizoma Cyperis of stir-fry, 7 parts of Herba Dendrobiis, 6 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Endothelium Corneum Gigeriae Galli, 6 parts of Rhizoma Coptidis, 12 parts of Rhizoma Dioscoreaes, 5 parts of Fructus Amomi Rotundus, 20 parts of Endoconcha Sepiaes, 12 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 10 parts of Radix Et Rhizoma Nardostachyos, 10 parts of Rhizoma Corydalis, 3 parts, Radix Glycyrrhizae.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 50 minutes, leaches medicinal liquid, obtains.
Embodiment 2
Drug weight proportioning:
20 parts of Cortex Magnoliae Officinalis, 25 parts of Rhizoma Cyperis of stir-fry, 14 parts of Herba Dendrobiis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Rhizoma Coptidis, 18 parts of Rhizoma Dioscoreaes, 10 parts of Fructus Amomi Rotundus, 30 parts of Endoconcha Sepiaes, 20 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 20 parts of Radix Et Rhizoma Nardostachyos, 20 parts of Rhizoma Corydalis, 7 parts, Radix Glycyrrhizae.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 65 minutes, leaches medicinal liquid, obtains.
Embodiment 3
Drug weight proportioning:
15 parts of Cortex Magnoliae Officinalis, 20 parts of Rhizoma Cyperis of stir-fry, 11 parts of Herba Dendrobiis, 9 parts of the Rhizoma Atractylodis Macrocephalaes, 9 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Rhizoma Coptidis, 15 parts of Rhizoma Dioscoreaes, 7 parts of Fructus Amomi Rotundus, 25 parts of Endoconcha Sepiaes, 16 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 16 parts of Radix Et Rhizoma Nardostachyos, 16 parts of Rhizoma Corydalis, 5 parts, Radix Glycyrrhizae.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 12 times of raw material weights to boil, after water boils, slow fire boils 80 minutes, leaches medicinal liquid, obtains.
Experimental example:
Below example is further set forth the beneficial effect that the present invention treats the Chinese medicine of gastric ulcer by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: gastric ulcer female patient 120 examples; 30~45 years old age.
B group: gastric ulcer male patient 140 examples; 30~50 years old age.
2, drug administration method:
Chinese medicine every day of the treatment gastric ulcer that the oral embodiment of the present invention 3 makes 2 times, each serving 250 grams, serve on 30 days.
3, efficacy evaluation:
(1) invalid: with take medicine before compare, without significant change.
(2) effective: effect is remarkable.
4, therapeutic effect:

Claims (3)

1. treat a Chinese medicine for gastric ulcer, it is characterized in that being made by the raw material of following weight proportioning:
Cortex Magnoliae Officinalis 10~20, stir-fry Rhizoma Cyperi 15~25, Herba Dendrobii 7~14, the Rhizoma Atractylodis Macrocephalae 6~12, Endothelium Corneum Gigeriae Galli 6~12, Rhizoma Coptidis 6~10, Rhizoma Dioscoreae 12~18, Fructus Amomi Rotundus 5~10, Endoconcha Sepiae 20~30, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12~20, Radix Et Rhizoma Nardostachyos 10~20, Rhizoma Corydalis 10~20, Radix Glycyrrhizae 3~7.
2. the Chinese medicine for the treatment of gastric ulcer according to claim 1, is characterized in that the weight proportion of each raw material is:
Cortex Magnoliae Officinalis 12~18, stir-fry Rhizoma Cyperi 18~22, Herba Dendrobii 9~12, the Rhizoma Atractylodis Macrocephalae 7~10, Endothelium Corneum Gigeriae Galli 7~10, Rhizoma Coptidis 7~9, Rhizoma Dioscoreae 14~16, Fructus Amomi Rotundus 6~9, Endoconcha Sepiae 22~28, the Pseudobulbus Bletillae (Rhizoma Bletillae) 14~18, Radix Et Rhizoma Nardostachyos 12~18, Rhizoma Corydalis 12~18, Radix Glycyrrhizae 4~6.
3. the Chinese medicine for the treatment of gastric ulcer according to claim 2, is characterized in that the weight proportion of each raw material is:
Cortex Magnoliae Officinalis 15, stir-fry Rhizoma Cyperi 20, Herba Dendrobii 11, the Rhizoma Atractylodis Macrocephalae 9, Endothelium Corneum Gigeriae Galli 9, Rhizoma Coptidis 8, Rhizoma Dioscoreae 15, Fructus Amomi Rotundus 7, Endoconcha Sepiae 25, the Pseudobulbus Bletillae (Rhizoma Bletillae) 16, Radix Et Rhizoma Nardostachyos 16, Rhizoma Corydalis 16, Radix Glycyrrhizae 5.
CN201310746748.1A 2013-12-30 2013-12-30 Traditional Chinese medicament for treating gastric ulcer Pending CN103705837A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310746748.1A CN103705837A (en) 2013-12-30 2013-12-30 Traditional Chinese medicament for treating gastric ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310746748.1A CN103705837A (en) 2013-12-30 2013-12-30 Traditional Chinese medicament for treating gastric ulcer

Publications (1)

Publication Number Publication Date
CN103705837A true CN103705837A (en) 2014-04-09

Family

ID=50399424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310746748.1A Pending CN103705837A (en) 2013-12-30 2013-12-30 Traditional Chinese medicament for treating gastric ulcer

Country Status (1)

Country Link
CN (1) CN103705837A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127420A (en) * 2014-07-17 2014-11-05 新乡医学院 Pharmaceutical composition for preventing liver cirrhosis and application thereof
CN105687627A (en) * 2016-02-29 2016-06-22 三峡大学 Traditional Chinese medicine composition for treating stomach bleeding and preparation method and application thereof
CN108355112A (en) * 2018-05-16 2018-08-03 重庆跃龙生物制药有限公司 Chinese medicine composition and its preparation method and application for treating gastric ulcer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1589881A (en) * 2004-04-22 2005-03-09 涂冲林 Chinese medicinal prescription for treating gastropathy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1589881A (en) * 2004-04-22 2005-03-09 涂冲林 Chinese medicinal prescription for treating gastropathy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朱岳耕: "胃溃疡中医药临床研究现状", 《吉林中医药》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127420A (en) * 2014-07-17 2014-11-05 新乡医学院 Pharmaceutical composition for preventing liver cirrhosis and application thereof
CN104127420B (en) * 2014-07-17 2016-12-07 新乡医学院第一附属医院 The pharmaceutical composition of prevention liver cirrhosis and application thereof
CN105687627A (en) * 2016-02-29 2016-06-22 三峡大学 Traditional Chinese medicine composition for treating stomach bleeding and preparation method and application thereof
CN108355112A (en) * 2018-05-16 2018-08-03 重庆跃龙生物制药有限公司 Chinese medicine composition and its preparation method and application for treating gastric ulcer

Similar Documents

Publication Publication Date Title
CN102038829A (en) Medicament for treating gastritis and ulcers of stomachs and duodenums
CN102078462A (en) Asthma relieving medicament
CN103705837A (en) Traditional Chinese medicament for treating gastric ulcer
CN103272126A (en) Traditional Chinese medicine for treating migraine
CN103211990B (en) Chinese medicinal composition for treating oral ulcer
CN103550643A (en) Traditional Chinese medicine for treating tuberculosis
CN103705855A (en) Traditional Chinese medicine for treating thyroiditis
CN103120789B (en) Traditional Chinese medicine composition for treating migraine
CN102727809B (en) Traditional Chinese medicine for treating infantile diarrhea
CN105796891A (en) Traditional Chinese medicinal composition for treating epigastric pain
CN104383097A (en) Traditional Chinese medicine for treating lupus erythematosus
CN104127668A (en) Traditional Chinese medicinal preparation for curing chronic pharyngitis
CN103479815A (en) Traditional Chinese medicine for treating urinary tract infection
CN104162119A (en) Traditional Chinese medicine for treating children&#39;s exogenous cough
CN101979056A (en) Traditional Chinese medicament for treating asthma
CN105727140A (en) Traditional Chinese medicine composition used for treating chronic renal failure
CN104873717A (en) Traditional Chinese medicine for treating climacteric syndromes
CN105434890A (en) Radiation stomatitis treating traditional Chinese medicine composition
CN104435979B (en) A kind of medicine for treating rheumatic lumbocrural pain pain
CN101979051A (en) Traditional Chinese medicine for treating chronic gastritis
CN103263516B (en) Medicine for treating cholecystitis
CN102488800B (en) Traditional Chinese medicine for treating periodontitis
CN103285199B (en) Traditional Chinese medicine wine for treating lumbocrural pain and preparation method of traditional Chinese medicine wine
CN103599355A (en) Traditional Chinese medicine for treating anorexia
CN104042784A (en) Traditional Chinese medicine composition for treating diarrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140409